Infertility
Tuesday, March 22, 2016
| 08:30-10:00 | SOCIAL FREEZING AND FREEZING TO ALL: THE DEBATE CONTINUES |
| Capsule | Female fertility preservation is a potent tool not only for cancer survivors but also for the current delay in family planning and the so called “social freezing”. Should we offer it to all? Freeze-all is also offered to substitute “fresh transfer to a compromised uterus”. What are the evidence? |
| Chairperson | Gab Kovacs, Australia Zion Ben-Rafael, Israel Marie-Madeleine Dolmans, Belgium |
| 08:30-09:15 | Debate: Social freezing or simply donor eggs Social freezing: Kate Stern, Australia Donor eggs: Gab Kovacs, Australia Discussion |
| 09:15-10:00 | Debate: Are the days of transferring “fresh embryos into a compromised uterus” coming to an end? Yes: Michael Chapman, Australia No: Norbert Gleicher, USA Discussion |
| 10:00-10:20 | Coffee break |
| 10:20-11:50 | FERTILITY PRESERVATION IN CANCER PATIENTS |
| Capsule | What are the prerequisites for successful preservation program? |
| Chairpersons | Norbert Gleicher, USA Gab Kovacs, Australia |
| 10:20-10:45 | Strategies of cryopreservation: What’s new? Masashige Kuwayama, Japan |
| 10:45-11:05 | Fertility preservation – What to freeze: eggs/embryo/ovarian tissue? Marie-Madeleine Dolmans, Belgium |
| 11:05-11:30 | Impact of apoptosis on follicle loss following cytotoxic treatment Karla J. Hutt, Australia |
| 11:30-11:50 | What clinical results can be expected after re-implantation? Jacques Donnez, Belgium |
| 11:50-12:10 | Break |
| 12:10-13:40 | AMH AND POOR OVARIAN RESERVE |
| Capsule | AMH is emerging as a leading test to predict ovarian response but can we do without it? The refinement of the assay promises to make this test more popular. |
| Chairpersons | Norbert Gleicher, USA Melanie L. Walls, Australia Ben W.J. Mol, Australia |
| 12:10-12:55 | Debate: Proposition: There is no place for ovarian reserve testing in modern fertility Ben W.J. Mol, Australia Position: Ovarian reserve tests are an important tool Ernest Ng, Hong Kong Discussion |
| 12:55-13:15 | Is there an ideal stimulation for POR? Gleicher Norbert, USA |
| 13:15-13:40 | Endometrioma excision and ovarian reserve Jacques Donnez, Belgium |
| 16:40-14:30 | Lunch break |
| 14:30-16:00 | EMBRYO IMPROVEMENT AND SELECTION FOR ET |
| Capsule | Newer techniques promise a better and more efficient selection for transfer and implantation |
| Chairpersons | Rebecca Robker, Australia Ernest Ng, Hong Kong |
| 14:30-14:55 | Embryo selection techniques and methodologies David K. Gardner, Australia |
| 14:55-15:15 | Is there really clinical value in embryo selection? Norbert Gleicher, USA |
| 15:15-15:40 | Mitochondrial transfer for oocyte rejuvenation Justin St. John, Australia |
| 15:40-16:00 | Biomarkers for endometrial receptivity are superior to genetic tests for implantation Tracey Edgell, Australia |
| 16:00-16:30 | Coffee break |
| 16:30-18:00 | IMPROVING PREGNANCY RATE BY PGS AND ENDOMETRIAL SCRATCH |
| Capsule | PGS is claimed to be successful in improving pregnancy rate, and some might even argue that it has to be universally applied, but yet differences in reported results and laboratories experience leave doubts on the clinical wisdom and cost effectiveness of expanding the use |
| Chairperson | David K. Gardner, Australia Gab Kovacs, Australia |
| 16:30-17:15 | Debate: PGS is now proven, every embryo should undergo PGS Yes: Gab Kovacs, Australia No: Norbert Gleicher, USA Discussion |
| Capsule | Despite numerous publication on the issue no agreement exist on the value of endometrial scratch to improve implantation |
| 17:15-18:00 | Debate: Proposition: Endometrial scratch can improve implantation Ernest Ng, Hong Kong Opposition: No proof that endometrial scratch can improve implantation Ben W.J. Mol, Australia Discussion |
Wednesday, March 23, 2016
| 08:30-10:00 | IMPROVING SPERM PERFORMANCE |
| Capsule | ICSI is being used with increasing frequency and in some clinics to all patients. ICSI also allows to use round spermatid. Are there any downsides to these practices? |
| Chairpersons | John Aitken, Australia Geoffry De Iuliis, Australia |
| 08:30-09:30 | Debate: ICSI for all cases? Yes: John Mcbain, Australia No: John Aitken, Australia Discussion |
| 09:30-10:00 | Why are RCTs rare in infertility and what to do about it? Norbert Gleicher, USA |
| 10:00-10:20 | Coffee break |
| 10:20-11:50 | THE ANDROLOGY LAB AND MALE INFERTILITY IN 2016 |
| Capsule | Male infertility research and sperm tests are plagued with several limitations that make it doubtful that there will ever be an “ultimate test” |
| Chairpersons | Geoffry De Iuliis, Australia R. John Aitken, Australia |
| 10:20-10:50 | The ultimate sperm “function test” R. John Aitken, Australia |
| 10:50-11:20 | Measuring sperm DNA damage: Are all tests created equal? Geoffry De Iuliis, Australia |
| 11:20-11:50 | Correlation between morphology, parthenogenesis and karyotype Budi Wiweko, Indonesia |
| 11:50-12:10 | Break |
| 12:10-13:40 | OVARIAN STIMULATION IN LOW AND HIGH RESPONDERS |
| Capsule | Effective stimulation of low responders and PCOS re still controversial |
| Chairpersons | David K. Gardner, Australia Salim Daya, Canada |
| 12:10-12:35 | PCOS: A complex reproductive, metabolic and psychology disorder Helena Teede, Australia |
| 12:35-12:55 | Use of metformin to improve outcome with IVF in PCOS Salim Daya, Canada |
| 12:55-13:40 | Debate : Do we need androgen supplementation in women with low ovarian reserve No: Salim Daya, Canada Yes: Norbert Gleicher, USA Discussion |
| 13:40-14:30 | Lunch break |
| 14:30-16:00 | CONTROLLED OVARIAN STIMULATION |
| Capsule | The ideal stimulation for these patients remains a great challenge for the clinician |
| Chairpersons | John Mcbain, Australia Ernest Ng, Hong Kong |
| 14:30-14:50 | How new infertility treatments negatively affected birth rates around the world over the last 10 years Gleicher Norbert, USA |
| 14:50-15:15 | IVM in PCOS – What results can be expected? Melanie L. Walls, Australia |
| 15:15-15:40 | Obesity-induced metabolic disruption of oocytes: The science behind the clinical relevance Rebecca Robker, Australia |
| 15:40-16:00 | Evidence based luteal support Salim Daya, Canada |
| 16:00-16:30 | Coffee break |
| 16:30-18:00 |
Hot Controversies RTD ON CLINICALLY AND LABORATORY RELATED CONTROVERSIES |
| Chairpersons | Zion Ben-Rafael, Israel Gab Kovacs, Australia |
| Discussants | David K. Gardner, Australia Norbert Gleicher, US Marie-Madeleine Dolmans, Belgium Lyndon Hale, Australia Salim Daya, Canada |
| Questions to the panel: | |
|